These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10802894)

  • 1. [Effect of hormone replacement therapy during the climacteric on cerebrovascular diseases].
    Römer T; Foth D; Griewing B
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):199-204. PubMed ID: 10802894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present position of the hormonal replacement therapy].
    Fait T; Vokrouhlická J; Vrablík M; Jenícek J
    Cas Lek Cesk; 2004; 143(7):447-52. PubMed ID: 15373286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Menopausal hormone replacement therapy and prevention of neurologic complications].
    Lopes P; Mensier A; Laurent FX; Besse O
    Contracept Fertil Sex; 1995 May; 23(5):319-22. PubMed ID: 7613577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk and hormone replacement therapy.
    Lawlor DA; Smith GD
    Curr Opin Obstet Gynecol; 2006 Dec; 18(6):658-65. PubMed ID: 17099339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Historical perspective of hormone replacement therapy].
    Chanson P
    Rev Prat; 2005 Feb; 55(4):369-75. PubMed ID: 15828614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy. An analysis of efficacy based on evidence.
    Gupta G; Aronow WS
    Geriatrics; 2002 Aug; 57(8):18-20, 23-4. PubMed ID: 12201226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alternatives to hormone replacement therapy: raloxifene and tibolone].
    von Holst T
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):205-9. PubMed ID: 10802895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of hormone replacement therapy with buspirone in the treatment of climacteric complaints].
    Szántó F
    Orv Hetil; 2000 Apr; 141(16):835-7. PubMed ID: 10817010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of hormone replacement therapy for climacteric symptoms.
    Takeo C; Ugai K; Araki J; Zhang L; Baba M; Ohashi W; Ueno K; Suzuki Y; Amano K; Hirai A; Muramatsu M
    Biochem Biophys Res Commun; 2008 Oct; 374(4):604-8. PubMed ID: 18627768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in hormone replacement therapy: perceptions and usage.
    Birkhäuser MH; Reinecke I
    Climacteric; 2008 Jun; 11(3):192-200. PubMed ID: 18568784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the effect of fluoxetine combined with hormone replacement therapy (HRT) and single HRT in treating menopausal depression].
    Yu Q; Yin CX; Hui Y; Yu J; He FF; Wei J; Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):461-4. PubMed ID: 15347469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.